NINDS recently issued a request for applications to establish clinical and data coordinating centers for a Parkinson’s Disease Biomarkers Identification Network (PD-BIN).
PD is a neurodegenerative disorder characterized by tremor, rigidity, bradykinesia, gait imbalance, and other motor, autonomic, sleep, neuropsychiatric, and cognitive symptoms. Although therapies to alleviate PD symptoms exist, none slow or prevent disease onset or progression. Efforts to develop such treatments have been hampered, at least in part, by the lack of reliable biologically-based identifiers for PD.
NINDS will fund a multi-site, multi-purpose PD-BIN to identify biological markers for PD risk, onset, and/or progression, and to encourage development of disease-modifying treatments. The purpose of this announcement is to invite applications to establish clinical and data coordinating centers for the network.
Letters of intent are due on December 18, 2010. Applications are due on January 18, 2011. Potential applicants should contact Dr. Katrina Gwinn, program director, Neurogenetics, NINDS, at 301-496-5745 or firstname.lastname@example.org, or visit http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-11-005.html.